Male reproductive endocrinology: When to replace gonadotropins

Seminars in Reproductive Medicine

Volumn 31, Issue 4, 2013, Pages 237-244

  Trussell, J C ^a  

^a University Hospital   (United States)

Author keywords

gonadotropin deficiency; hypogonadotropic hypogonadism; male infertility; recombinant; replacement

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT PROTEIN;

ARTICLE; ENDOCRINOLOGY; HORMONE RELEASE; HUMAN; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; HYPOPHYSIS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IDIOPATHIC DISEASE; KALLMANN SYNDROME; LEYDIG CELL; MALE GENITAL SYSTEM; MALE INFERTILITY; OBSTRUCTIVE AZOOSPERMIA; PROLACTINOMA; SERTOLI CELL; SPERMATOGENESIS; SPERMATOZOON COUNT; TESTIS; TESTIS DISEASE; UNPROTECTED SEX; DEFICIENCY; DRUG EFFECTS; GENETICS; HORMONE SUBSTITUTION; INFERTILITY, MALE; MALE; METABOLISM; PATHOPHYSIOLOGY; SECRETION (PROCESS);

CHORIONIC GONADOTROPIN; FOLLICLE STIMULATING HORMONE; GONADOTROPINS; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; HYPOTHALAMUS; INFERTILITY, MALE; LUTEINIZING HORMONE; MALE; MENOTROPINS; PITUITARY GLAND; RECOMBINANT PROTEINS; TESTIS;

EID: 84879237814     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0033-1345270     Document Type: Article

References (64)

1. Guttmacher A. F. Factors affecting normal expectancy of conception. J Am Med Assoc: 1956; 161 9 855 860
2. de Kretser D. M. Male infertility. Lancet: 1997; 349 9054 787 790
3. Krieger D. T. The hypothalamus and neuroendocrine pathology. In: Krieger D. T., Hughes J. C., eds. Neuroendocrinology. Sunderland, MA Sinauer Associates: 1980; 13
4. Braak H., Braak E. Anatomy of the human hypothalamus (chiasmatic and tuberal region). Prog Brain Res: 1992; 93 3 14, discussion 14-16
5. Skynner M. J., Sim J. A., Herbison A. E. Detection of estrogen receptor alpha and beta messenger ribonucleic acids in adult gonadotropin-releasing hormone neurons. Endocrinology: 1999; 140 11 5195 5201
6. Roy D., Angelini N. L., Belsham D. D. Estrogen directly represses gonadotropin-releasing hormone (GnRH) gene expression in estrogen receptor-alpha (ERalpha)- and ERbeta-expressing GT1-7 GnRH neurons. Endocrinology: 1999; 140 11 5045 5053
7. Ojeda S. R., Ma Y. J. Glial-neuronal interactions in the neuroendocrine control of mammalian puberty: facilitatory effects of gonadal steroids. J Neurobiol: 1999; 40 4 528 540
8. Santen R. J. Is aromatization of testosterone to estradiol required for inhibition of luteinizing hormone secretion in men? J Clin Invest: 1975; 56 6 1555 1563
9. Gu Y., Liang X., Wu W., et al. Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men. J Clin Endocrinol Metab: 2009; 94 6 1910 1915
10. Clarke I. J. Variable patterns of gonadotropin-releasing hormone secretion during the estrogen-induced luteinizing hormone surge in ovariectomized ewes. Endocrinology: 1993; 133 4 1624 1632
11. Levallet J., Pakarinen P., Huhtaniemi I. T. Follicle-stimulating hormone ligand and receptor mutations, and gonadal dysfunction. Arch Med Res: 1999; 30 6 486 494
12. Tapanainen J. S., Aittomäki K., Min J., Vaskivuo T., Huhtaniemi I. T. Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat Genet: 1997; 15 2 205 206
13. Hayes F. J., Crowley W. F. Jr. Gonadotropin pulsations across development. Horm Res: 1998; 49 3-4 163 168
14. de Kretser D. M., Robertson D. M. The isolation and physiology of inhibin and related proteins. Biol Reprod: 1989; 40 1 33 47
15. de Kretser D. M., Meinhardt A., Meehan T., Phillips D. J., O'Bryan M. K., Loveland K. A. The roles of inhibin and related peptides in gonadal function. Mol Cell Endocrinol: 2000; 161 1-2 43 46
16. Dearth R. K., Hiney J. K., Dees W. L. Leptin acts centrally to induce the prepubertal secretion of luteinizing hormone in the female rat. Peptides: 2000; 21 3 387 392
17. Tena-Sempere M., Pinilla L., González L. C., et al. In vitro pituitary and testicular effects of the leptin-related synthetic peptide leptin(116-130) amide involve actions both similar to and distinct from those of the native leptin molecule in the adult rat. Eur J Endocrinol: 2000; 142 4 406 410
18. Roth M. Y., Page S. T., Lin K., et al. Dose-dependent increase in intratesticular testosterone by very low-dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiency. J Clin Endocrinol Metab: 2010; 95 8 3806 3813
19. Schlegel P. N., Hardy M. Male reproductive physiology. In: Walsh P., ed. Campbell's Urology. 8th ed. Philadelphia, PA Saunders Elsevier: 2002; 1437 1474
20. Lyon M. F., Glenister P. H., Lamoreux M. L. Normal spermatozoa from androgen-resistant germ cells of chimaeric mice and the role of androgen in spermatogenesis. Nature: 1975; 258 5536 620 622
21. Moudgal N. R., Sairam M. R. Is there a true requirement for follicle stimulating hormone in promoting spermatogenesis and fertility in primates? Hum Reprod: 1998; 13 4 916 919
22. Plant T. M., Marshall G. R. The functional significance of FSH in spermatogenesis and the control of its secretion in male primates. Endocr Rev: 2001; 22 6 764 786
23. Pareek T. K., Joshi A. R., Sanyal A., Dighe R. R. Insights into male germ cell apoptosis due to depletion of gonadotropins caused by GnRH antagonists. Apoptosis: 2007; 12 6 1085 1100
24. Schoor R. A., Elhanbly S., Niederberger C. S., Ross L. S. The role of testicular biopsy in the modern management of male infertility. J Urol: 2002; 167 1 197 200
25. Meier C., Christ-Crain M., Christoffel-Courtin C., Staub J. J., Müller B. Serum estradiol after single dose hCG administration correlates with Leydig cell reserve in hypogonadal men: reassessment of the hCG stimulation test. Clin Lab: 2005; 51 9-10 509 515
26. Lanfranco F., Kamischke A., Zitzmann M., Nieschlag E. Klinefelter's syndrome. Lancet: 2004; 364 9430 273 283
27. Stearns G., Turek P. Avoiding toxins including spermatotoxic medications. Semin Reprod Med: 2013; 31 4 286 292
28. Showell M. G., Brown J., Yazdani A., Stankiewicz M. T., Hart R. J. Antioxidants for male subfertility. Cochrane Database Syst Rev: 2011; 1 CD007411
29. Snyder P. J., Matsumoto A. M., Kirkland J. L., Martin K. A. Causes of secondary hypogonadism in males. UpToDate.: 2012; 19 3 1 15
30. Burgués S., Calderón M. D. Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Hum Reprod: 1997; 12 5 980 986
31. European Metrodin HP Study Group Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic hypogonadism. Fertil Steril: 1998; 70 2 256 262
32. Daya S. Follicle-stimulating hormone in clinical practice: an update. Treat Endocrinol: 2004; 3 3 161 171
33. Bouloux P., Warne D. W., Loumaye E. FSH Study Group in Men's Infertility Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism. Fertil Steril: 2002; 77 2 270 273
34. Liu P. Y., Turner L., Rushford D., et al. Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men. Hum Reprod: 1999; 14 6 1540 1545
35. Kliesch S., Behre H. M., Nieschlag E. Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male. Fertil Steril: 1995; 63 6 1326 1328
36. Spratt D. I., Finkelstein J. S., O'Dea L. S., et al. Long-term administration of gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism. A model for studies of the hormone's physiologic effects. Ann Intern Med: 1986; 105 6 848 855
37. Pitteloud N., Hayes F. J., Dwyer A., Boepple P. A., Lee H., Crowley W. F. Jr. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab: 2002; 87 9 4128 4136
38. McClure R. D. Endocrine investigation and therapy. Urol Clin North Am: 1987; 14 3 471 488
39. Finkelstein J. S., Klibanski A., Neer R. M., Greenspan S. L., Rosenthal D. I., Crowley W. F. Jr. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med: 1987; 106 3 354 361
40. Finkel D. M., Phillips J. L., Snyder P. J. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med: 1985; 313 11 651 655
41. Howles C. M., Tanaka T., Matsuda T. Management of male hypogonadotrophic hypogonadism. Endocr J: 2007; 54 2 177 190
42. Liu P. Y., Baker H. W., Jayadev V., Zacharin M., Conway A. J., Handelsman D. J. Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome. J Clin Endocrinol Metab: 2009; 94 3 801 808
43. Kung A. W., Zhong Y. Y., Lam K. S., Wang C. Induction of spermatogenesis with gonadotrophins in Chinese men with hypogonadotrophic hypogonadism. Int J Androl: 1994; 17 5 241 247
44. Saal W., Happ J., Cordes U., Baum R. P., Schmidt M. Subcutaneous gonadotropin therapy in male patients with hypogonadotropic hypogonadism. Fertil Steril: 1991; 56 2 319 324
45. Burris A. S., Rodbard H. W., Winters S. J., Sherins R. J. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. J Clin Endocrinol Metab: 1988; 66 6 1144 1151
46. Büchter D., Behre H. M., Kliesch S., Nieschlag E. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol: 1998; 139 3 298 303
47. Miyagawa Y., Tsujimura A., Matsumiya K., et al. Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: a 30-year retrospective study. J Urol: 2005; 173 6 2072 2075
48. Warne D. W., Decosterd G., Okada H., Yano Y., Koide N., Howles C. M. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. Fertil Steril: 2009; 92 2 594 604
49. McLachlan R. I., Finkel D. M., Bremner W. J., Snyder P. J. Serum inhibin concentrations before and during gonadotropin treatment in men with hypogonadotropic hypogonadism: physiological and clinical implications. J Clin Endocrinol Metab: 1990; 70 5 1414 1419
50. Chan C. C., Ng E. H., Chan M. M., et al. Bioavailability of hCG after intramuscular or subcutaneous injection in obese and non-obese women. Hum Reprod: 2003; 18 11 2294 2297
51. Steinkampf M. P., Hammond K. R., Nichols J. E., Slayden S. H. Effect of obesity on recombinant follicle-stimulating hormone absorption: subcutaneous versus intramuscular administration. Fertil Steril: 2003; 80 1 99 102
52. Matsumoto A. M., Snyder P. J., Bhasin S., et al. Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism. Fertil Steril: 2009; 92 3 979 990
53. Yazici M., Sahin M., Bolu E., et al. Prediction of testosterone response to human chorionic gonadotrophin in idiopathic hypogonadotropic hypogonadism patients. J Natl Med Assoc: 2009; 101 1 71 76
54. Anawalt B. D., Bebb R. A., Matsumoto A. M., et al. Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab: 1996; 81 9 3341 3345
55. Ramaswamy S., Marshall G. R., McNeilly A. S., Plant T. M. Evidence that in a physiological setting Sertoli cell number is the major determinant of circulating concentrations of inhibin B in the adult male rhesus monkey (Macaca mulatta). J Androl: 1999; 20 3 430 434
56. Winters S. J., Wang C., Abdelrahaman E., Hadeed V., Dyky M. A., Brufsky A. Inhibin-B levels in healthy young adult men and prepubertal boys: is obesity the cause for the contemporary decline in sperm count because of fewer Sertoli cells? J Androl: 2006; 27 4 560 564
57. Pitteloud N., Hayes F. J., Dwyer A., Boepple P. A., Lee H., Crowley W. F. Jr. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab: 2002; 87 9 4128 4136
58. Heber D., Marshall J. C., Odell W. D. GnRH membrane binding: identification, specificity, and quantification in nonpituitary tissues. Am J Physiol: 1978; 235 2 E227 E230
59. Coviello A. D., Matsumoto A. M., Bremner W. J., et al. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J Clin Endocrinol Metab: 2005; 90 5 2595 2602
60. Liu P. Y., Swerdloff R. S., Christenson P. D., Handelsman D. J., Wang C. Hormonal Male Contraception Summit Group Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet: 2006; 367 9520 1412 1420
61. Claustrat B., David L., Faure A., Francois R. Development of anti-human chorionic gonadotropin antibodies in patients with hypogonadotropic hypogonadism. A study of four patients. J Clin Endocrinol Metab: 1983; 57 5 1041 1047
62. Thau R. B., Goldstein M., Yamamoto Y., Burrow G. N., Phillips D., Bardin C. W. Failure of gonadotropin therapy secondary to chorionic gonadotropin-induced antibodies. J Clin Endocrinol Metab: 1988; 66 4 862 867
63. Bhasin S., Cunningham G. R., Hayes F. J., et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab: 2006; 91 6 1995 2010
64. Sexson E., Knezevich J. Male hypogonadism: a review of the disease and its treatment. US Pharm: 2010; 35 7 16